The 47% operating EPS growth and raised guidance signal strong underlying momentum, but the $44.9M actuarial review benefit is non-recurring. Monitor Q4 2026 for normalized earnings power and the impact of the October reinsurance transaction on statutory capital and deployable cash.
Price Chart
Executive Summary
CNO Financial Group reported Q3 2026 net operating income of $1.90 per diluted share, beating the $1.10 consensus by 72.7%, driven by a $44.9 million favorable impact from the annual actuarial review. The company raised its full-year 2026 operating EPS guidance by 9% at the midpoint, marking the 17th consecutive quarter of sales growth.
Key Financial Metrics
Key Facts
- Net operating income of $1.90 per diluted share vs. consensus $1.10 (beat by 72.7%)
- Full-year 2026 operating EPS guidance raised, midpoint up 9% from prior guidance
- Net income of $161.1M ($1.71 per diluted share) vs. $23.1M ($0.24) in Q3 2025
- Operating EPS grew 47% year-over-year in the quarter
- Total new annualized premiums (NAP) up for 17th consecutive quarter
- Book value per diluted share ex-AOCI of $41.29, up 8% year-over-year
- Repurchased $60.0M of common stock in Q3 2026 at avg $54.52/share
- Closed 3rd reinsurance transaction with Bermuda affiliate on Oct 1, 2026, reinsuring ~$270M of reserves
- Statutory RBC ratio of 374% at Sep 30, 2026
Financial Impact
Net operating income of $179.1M ($1.90/diluted share) vs. consensus $1.10; guidance raised 9% at midpoint
Risk Factors
- Q3 2026 results include a $44.9M favorable item from the annual actuarial review ($0.48/diluted share), which may not recur
- Net realized investment losses of $48.3M in Q3 2026 vs. $8.8M in Q3 2025
- Debt-to-capital ratio increased to 36.5% from 33.6% at Dec 31, 2025
- Unrestricted cash at holding company declined to $230.7M from $351.4M at Dec 31, 2025
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302924231 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 3d ago | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
Oct 29, 2026 3d ago | Press Release | $57.60 | awaiting T+60 | awaiting T+60 | $57.67 (+0.12%) |
Oct 15, 2026 17d ago | Press Release | $54.71 | awaiting T+60 | awaiting T+60 | $57.67 (+5.41%) |
Sep 2, 2026 8w ago | Insider Cluster | $56.72 | awaiting T+60 | awaiting T+60 | $57.67 (+1.67%) |
Sep 1, 2026 8w ago | 8-K | $54.54 | awaiting T+60 | awaiting T+60 | $57.67 (+5.74%) |
Aug 5, 2026 12w ago | Press Release | $55.48 $55.17 | ▼ −0.56% | ▲ +0.87% | $57.67 (+3.95%) |
Jul 30, 2026 13w ago | Press Release | $55.09 $54.20 | ▼ −1.62% | ▼ −4.07% | $57.67 (+4.68%) |
Jul 1, 2026 17w ago | Insider Cluster | $52.43 $53.64 | ▲ +2.31% | ▼ −0.49% | $57.67 (+9.99%) |
Mar 26, 2026 31w ago | DEFA14A | No price | awaiting T+60 | awaiting T+60 | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers